Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Aptiv Increases Tender Offer by $21 Million

Aptiv lifted the size of its cash tender offer by $21 million, increasing the maximum aggregate consideration to $1.371 billion from $1.35 billion, after early tenders showed strong participation across all seven note series.

By the early tender deadline, holders had submitted $2.46 billion of notes against $4.63 billion outstanding across the targeted bonds. The largest response came in Aptiv’s 3.100% senior notes due 2051, where $691.9 million was tendered out of $1.5 billion outstanding. The 4.150% senior notes due 2052 drew $415.1 million of tenders against $1.0 billion outstanding.

Other series also saw substantial participation: $447.6 million of the 3.250% senior notes due 2032 was tendered from $717.2 million outstanding; $367.0 million of the 5.150% senior notes due 2034 from $515.9 million outstanding; and $302.3 million of the 5.750% senior notes due 2054 from $550.0 million outstanding. The 5.400% senior notes due 2049 drew $123.5 million of tenders from $350.0 million outstanding, while the 4.400% senior notes due 2046 attracted $111.7 million from $300.0 million outstanding.

Aptiv said the tender remains subject to the planned separation of its electrical distribution systems business into Versigent and a special dividend from that business of at least $1.7 billion. Settlement is currently expected on April 7, 2026. As a result of these announcements, the company's shares have moved -4.84% on the market, and are now trading at a price of $78.61. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS